Daiichi Sankyo Vanflyta
-
Drug News
FDA Grants Approval to Vanflyta (Quizartinib) for Acute Myeloid Leukemia with Positive Results
On the 20th of July, 2023, Daiichi Sankyo (TSE: 4568) announced that Vanflyta (quizartinib) has been approved by the U.S. Food and…
Read More »
